Addex convenes annual general meeting 2024

Ad hoc announcement pursuant to art. 53 lr geneva, switzerland, june 5, 2024 - addex therapeutics (six: adxn and nasdaq: adxn), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today that its 2024 annual general meeting will take place on friday june 28, 2024, at 11:00 am cest at the campus biotech, chemin des mines 9, 1202 geneva (doors open at 10:30 am).
GM Ratings Summary
Quant
GM Quant Ranking
Sector
Industry
Quant Rating
Quant Score